Bortenat 2mg Injection

Bortenat 2 mg injection belongs to the class of drugs called proteasome inhibitors. Proteasomes are proteins which play an important role in growth and multiplication of cancer cells. Bortenat 2 mg injection blocks the action of the proteasome, and reduces the growth of cancerous (actively growing) cells.
Bortenat from Natco contains Bortezomib.
Below are some of the details of Bortezomib(generic).
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.
 

Expert advice for Bortenat 2 mg Injection

• Before taking bortezomib, consult your doctor if you have any of the following disease conditions: the disease of liver, kidney, heart or infections like fever with rash or genital sores, diabetes, low number of red or white blood cells or bleeding problems.
• Drink plenty of fluids every day during your treatment with bortezomib.
• Tell your doctor if you are or planning to become pregnant or are breastfeeding.
• Consult your doctor if you have signs of serious brain infection such as memory loss, trouble with thinking, difficulty with walking or loss of vision.
• Do not drive or operate machinery after taking bortezomib as it may cause tiredness, dizziness, fainting or blurred vision.